Jubilant Pharmova Ltd.

NSE: JUBLPHARMA | BSE: 530019 | ISIN: INE700A01033 | Industry: Pharmaceuticals
| Falling Comet
956.1000 -11.90 (-1.23%)
NSE Jan 23, 2026 15:31 PM
Volume: 139.6K
 

announcement
Conference/Earnings Calls Alerts
956.10
-1.23%
Management Call: Jubilant Life Sciences on Covid impact

Conference Call with Management of Jubilant Life Sciences and Analysts on covid impact. Listen in on the full transcript here

Key Remarks

- The world is in an unprecedented situation due to Covid-19

- The Indian government has responded strongly, but we are already seeing economic impact particularly low income households and migrants

- The good news is that we are currently seeing strong performance, thanks to diversity in geos, and most of our businesses are under essential business category

- We have ensured adequate stock right now of raw material. Diligently monitoring our supply situation in US and Canada. We have largely been able to keep our plants running

 - The Nanjangud plant saw closure for a few days after two workers tested positive for covid.

More from Jubilant Pharmova Ltd.
Recommended